|
| | Publication Year | Title | Author(s) |
| 1 | Apr-2018 | 68Ga-prostate specific membrane antigen (PSMA) positron emission tomography (PET) for primary staging of high-risk prostate cancer: a systematic review | Corfield, Julia; Perera, Marlon ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 2 | Dec-2017 | 68Ga-prostate-specific membrane antigen-positron emission tomography/computed tomography in advanced prostate cancer: Current state and future trends. | Udovicich, Cristian; Perera, Marlon ; Hofman, Michael S; Siva, Shankar; Del Rio, Andres ; Murphy, Declan G; Lawrentschuk, Nathan |
| 3 | 4-Jun-2020 | A systematic scoping review of multidisciplinary cancer team and decision-making in the management of men with advanced prostate cancer. | Holmes, A; Kelly, Brian D ; Perera, Marlon ; Eapen, Renu S ; Bolton, Damien M ; Lawrentschuk, Nathan |
| 4 | May-2022 | Adjuvant therapies for non-muscle-invasive bladder cancer: advances during BCG shortage. | Balasubramanian, Adithya ; Gunjur, Ashray ; Weickhardt, Andrew J ; Papa, Nathan; Bolton, Damien M ; Lawrentschuk, Nathan; Perera, Marlon |
| 5 | 2019 | Analysis of social media use among Australian and New Zealand otolaryngologists. | Baird, Samantha M; Marsh, Philip A; Lawrentschuk, Nathan; Smart, Philip ; Chow, Zenia |
| 6 | Jul-2021 | Assessment and management of haematuria in the general practice setting. | O'Connor, Ellen ; McVey, Aoife ; Demkiw, Stephanie; Lawrentschuk, Nathan; Murphy, Declan G |
| 7 | Sep-2017 | Atypical small acinar proliferation and high grade prostatic intraepithelial neoplasia in the era of multi-parametric MRI: a contemporary review | Manning, Todd G ; Cheung, Ernest ; Perera, Marlon ; Christidis, Daniel; O'Brien, Jonathan S; Mitchell, Catherine; Bolton, Damien M ; Lawrentschuk, Nathan |
| 8 | Jul-2020 | Bacillus Calmette Guérin (BCG) vaccination use in the fight against COVID-19 - what's old is new again? | O'Connor, Ellen ; Teh, Jiasian ; Kamat, Ashish M; Lawrentschuk, Nathan |
| 9 | Dec-2017 | Blueprint unknown: a case for multidisciplinary management of advanced penile mycosis fungoides | O'Brien, JS; Manning, Todd G ; Perera, Marlon ; Prince, Miles H; Lawrentschuk, Nathan |
| 10 | 2022 | A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy. | Lim Joon, Daryl ; Berry, Colleen ; Harris, Benjamin; Tacey, Mark A ; Smith, Drew; Lawrentschuk, Nathan; Schneider, Michal Elisabeth; Fraser, Olivia; Hall, Megan; Chao, Michael ; Foroudi, Farshad ; Jenkins, Trish ; Angus, David ; Wada, Morikatsu ; Sengupta, Shomik ; Khoo, Vincent |
| 11 | 2021 | Clinical trials in urological oncology: COVID-19 and the potential need for a new perspective. | Teh, Jiasian ; O'Connor, Ellen ; Coles-Black, Jasamine ; Lawrentschuk, Nathan |
| 12 | Apr-2019 | Comparative sensitivity and specificity of imaging modalities in staging bladder cancer prior to radical cystectomy: a systematic review and meta-analysis. | Crozier, Jack; Papa, Nathan P; Perera, Marlon ; Ngo, Brian ; Bolton, Damien M ; Sengupta, Shomik ; Lawrentschuk, Nathan |
| 13 | 28-Nov-2023 | Comparison of 18F-based PSMA radiotracers with [68Ga]Ga-PSMA-11 in PET/CT imaging of prostate cancer-a systematic review and meta-analysis. | Huang, Siyu; Ong, Sean; McKenzie, Dean; Mirabelli, Adam; Chen, David C; Chengodu, Thilakavathi; Murphy, Declan G; Hofman, Michael S; Lawrentschuk, Nathan; Perera, Marlon |
| 14 | 21-Apr-2022 | Cribriform pattern disease over-represented in pelvic lymph node metastases identified on 68GA PSMA-PET/CT. | Bolton, Damien M ; Hong, Anne; Papa, Nathan; Perera, Marlon ; Kelly, Brian D ; Duncan, Catriona; Clouston, David; Lawrentschuk, Nathan |
| 15 | 2022 | Critical shortage in BCG immunotherapy: How did we get here and where will it take us? | Harvey, Michael; Chislett, Bodie ; Perera, Marlon ; Lawrentschuk, Nathan; Bolton, Damien M ; Jack, Gregory S |
| 16 | Apr-2020 | Declining use of radical prostatectomy and pelvic lymphadenectomy despite more robotics: National population data over 15 years. | Roberts, Matthew J; Papa, Nathan P; Perera, Marlon ; Joshi, Andre; Scott, Susan; Bolton, Damien M ; Lawrentschuk, Nathan; Yaxley, John |
| 17 | 13-Dec-2022 | Distant Nodes Seen on PSMA PET-CT Staging Predicts Post-Treatment Progression in Men with Newly Diagnosed Prostate Cancer-A Prospective Cohort Study. | Ong, Sean; Pascoe, Claire; Kelly, Brian D ; Ballok, Zita; Webb, David ; Bolton, Damien M ; Murphy, Declan; Sengupta, Shomik ; Bowden, Patrick; Lawrentschuk, Nathan |
| 18 | May-2021 | Ductal variant prostate carcinoma is associated with a significantly shorter metastasis-free survival. | Chow, Ken; Bedő, Justin; Ryan, Andrew; Agarwal, Dinesh; Bolton, Damien M ; Chan, Yee ; Dundee, Philip; Frydenberg, Mark; Furrer, Marc A; Goad, Jeremy; Gyomber, Dennis ; Hanegbi, Uri; Harewood, Laurence; King, Dennis; Lamb, Alastair D; Lawrentschuk, Nathan; Liodakis, Peter ; Moon, Daniel; Murphy, Declan G; Peters, Justin S; Ruljancich, Paul; Verrill, Clare L; Webb, David ; Wong, Lih-Ming ; Zargar, Homayoun; Costello, Anthony J; Papenfuss, Anthony T; Hovens, Christopher M; Corcoran, Niall M |
| 19 | 29-Jan-2006 | Fixed drug eruption of the penis secondary to sulfamethoxazole-trimethoprim. | Lawrentschuk, Nathan; Pan, David; Troy, Andrew J |
| 20 | Oct-2020 | Future directions in advanced penile cancer - mechanisms of carcinogenesis and a search for targeted therapy. | Teh, Jiasian ; O'Connor, Ellen ; O'Brien, Jonathon; Lim, Wei Mou; Taylor, Michael; Heriot, Alexander; Ramsay, Robert; Lawrentschuk, Nathan |
